Received May 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | X011431 | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
No adverse event; Caller reported AE on behalf of a patient who was administered expired MMR-II on 04/24/2025 w/ no TEs-- SUPPORTED via post-expiry memo. No symptoms reported. No additional AE details reported. Obtained consent to contact HCP. Additional AEs Filed (Ca; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 24-Apr-2025, the patient was vaccinated with expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), lot #X011431, expiration date: 19-Apr-2025, 0.5 mL (formulation, route of administration and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (expired vaccine used). No additional adverse event reported (no adverse event).